Synthio Labs, a startup specializing in clinical-grade voice AI for the life sciences sector, has successfully raised $5 million in a seed funding round. The investment was spearheaded by Elevation Capital, with notable participation from 1984 Ventures, Peak XV Partners, Y Combinator, and various strategic angels.
Funds Earmarked for Expansion and Deployment
The newly acquired capital will be strategically utilized to fuel the company’s ambitious growth plans, including:
-
Expanding its engineering and product teams.
-
Scaling enterprise deployments across the U.S. and Europe.
-
Deepening partnerships with global life sciences companies.
About Synthio Labs and Its AI Platform
Founded by Supreet Deshpande, Sahitya Sridhar, and Rajashekar Vasantha, Synthio Labs develops AI solutions that streamline communication among life sciences companies, clinicians, and patients.
Synthio’s AI operating system features three core products:
-
Jarvis: A voice AI copilot designed for field teams.
-
Ather: A multimodal engine that facilitates physician and patient engagement across multiple channels.
-
Simulation Studio: A tool for creating digital twins of clinicians and patients, used for research and strategy.
These innovative tools are designed to automate conversations, gather structured intelligence, and ensure consistent communication across the healthcare ecosystem.
Significant Early Adoption
Synthio’s technology is already being adopted by several top pharmaceutical companies and D2C healthcare brands. A key example of its efficiency is a project where Synthio’s voice AI successfully completed 5,000 calls to eczema patients in just 48 hours for onboarding, screening, and assistance purposes.
By: Sandhya Bharti
